Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of COVID-19 RNA Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of COVID-19 RNA Vaccine market, defines the market attractiveness level of COVID-19 RNA Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of COVID-19 RNA Vaccine industry, describes the types of COVID-19 RNA Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global COVID-19 RNA Vaccine market and the development prospects and opportunities of COVID-19 RNA Vaccine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global COVID-19 RNA Vaccine market in Chapter 13.
By Player:
ARCoV
Janssen
Pfizer
Stemirna Therapeutics
CureVac
Moderna
Zhuhai Livanda Biotechnology Co, Ltd
By Type:
One Shots
Two Shots
By End-User:
Over 16 Years Old
12-15 YearsOld
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 COVID-19 RNA Vaccine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 COVID-19 RNA Vaccine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 COVID-19 RNA Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 COVID-19 RNA Vaccine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise COVID-19 RNA Vaccine Market Analysis and Outlook to 2022
-
7.1 Global COVID-19 RNA Vaccine Consumption (2017-2022)
-
7.2 United States COVID-19 RNA Vaccine Consumption (2017-2022)
-
7.3 Europe COVID-19 RNA Vaccine Consumption (2017-2022)
-
7.4 China COVID-19 RNA Vaccine Consumption (2017-2022)
-
7.5 Japan COVID-19 RNA Vaccine Consumption (2017-2022)
-
7.6 India COVID-19 RNA Vaccine Consumption (2017-2022)
-
7.7 South Korea COVID-19 RNA Vaccine Consumption (2017-2022)
8 Region and Country-wise COVID-19 RNA Vaccine Market Analysis and Outlook to 2028
-
8.1 Global COVID-19 RNA Vaccine Consumption Forecast (2022-2028)
-
8.2 United States COVID-19 RNA Vaccine Consumption Forecast (2022-2028)
-
8.3 Europe COVID-19 RNA Vaccine Consumption Forecast (2022-2028)
-
8.4 China COVID-19 RNA Vaccine Consumption Forecast (2022-2028)
-
8.5 Japan COVID-19 RNA Vaccine Consumption Forecast (2022-2028)
-
8.6 India COVID-19 RNA Vaccine Consumption Forecast (2022-2028)
-
8.7 South Korea COVID-19 RNA Vaccine Consumption Forecast (2022-2028)
9 Global COVID-19 RNA Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global COVID-19 RNA Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global One Shots Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Two Shots Consumption and Growth Rate (2017-2022)
-
9.2 Global COVID-19 RNA Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Over 16 Years Old Consumption and Growth Rate (2017-2022)
-
9.2.2 Global 12-15 YearsOld Consumption and Growth Rate (2017-2022)
10 Global COVID-19 RNA Vaccine Market Outlook by Types and Applications to 2028
-
10.1 Global COVID-19 RNA Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global One Shots Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Two Shots Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global COVID-19 RNA Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Over 16 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global 12-15 YearsOld Consumption Forecast and Growth Rate (2022-2028)
11 Global COVID-19 RNA Vaccine Import and Export Analysis (Top 5 Countries)
-
11.1 Global COVID-19 RNA Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global COVID-19 RNA Vaccine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 COVID-19 RNA Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global COVID-19 RNA Vaccine Market Competitive Analysis
-
14.1 ARCoV
-
14.1.1 ARCoV Company Details
-
14.1.2 ARCoV COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 ARCoV COVID-19 RNA Vaccine Product and Service
-
14.2 Janssen
-
14.2.1 Janssen Company Details
-
14.2.2 Janssen COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Janssen COVID-19 RNA Vaccine Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer COVID-19 RNA Vaccine Product and Service
-
14.4 Stemirna Therapeutics
-
14.4.1 Stemirna Therapeutics Company Details
-
14.4.2 Stemirna Therapeutics COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Stemirna Therapeutics COVID-19 RNA Vaccine Product and Service
-
14.5 CureVac
-
14.5.1 CureVac Company Details
-
14.5.2 CureVac COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 CureVac COVID-19 RNA Vaccine Product and Service
-
14.6 Moderna
-
14.6.1 Moderna Company Details
-
14.6.2 Moderna COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Moderna COVID-19 RNA Vaccine Product and Service
-
14.7 Zhuhai Livanda Biotechnology Co, Ltd
-
14.7.1 Zhuhai Livanda Biotechnology Co, Ltd Company Details
-
14.7.2 Zhuhai Livanda Biotechnology Co, Ltd COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Zhuhai Livanda Biotechnology Co, Ltd COVID-19 RNA Vaccine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of COVID-19 RNA Vaccine
-
Figure COVID-19 RNA Vaccine Picture
-
Table Global COVID-19 RNA Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global COVID-19 RNA Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global COVID-19 RNA Vaccine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global COVID-19 RNA Vaccine Consumption by Country (2017-2022)
-
Figure United States COVID-19 RNA Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe COVID-19 RNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure China COVID-19 RNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan COVID-19 RNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India COVID-19 RNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea COVID-19 RNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global COVID-19 RNA Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States COVID-19 RNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe COVID-19 RNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China COVID-19 RNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan COVID-19 RNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India COVID-19 RNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea COVID-19 RNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global One Shots Consumption and Growth Rate (2017-2022)
-
Figure Global Two Shots Consumption and Growth Rate (2017-2022)
-
Figure Global Over 16 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global 12-15 YearsOld Consumption and Growth Rate (2017-2022)
-
Figure Global One Shots Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Two Shots Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Over 16 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 12-15 YearsOld Consumption Forecast and Growth Rate (2022-2028)
-
Table Global COVID-19 RNA Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global COVID-19 RNA Vaccine Export by Region (Top 5 Countries) (2017-2028)
-
Table ARCoV (Foundation Year, Company Profile and etc.)
-
Table ARCoV COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table ARCoV COVID-19 RNA Vaccine Product and Service
-
Table Janssen (Foundation Year, Company Profile and etc.)
-
Table Janssen COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen COVID-19 RNA Vaccine Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer COVID-19 RNA Vaccine Product and Service
-
Table Stemirna Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Stemirna Therapeutics COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stemirna Therapeutics COVID-19 RNA Vaccine Product and Service
-
Table CureVac (Foundation Year, Company Profile and etc.)
-
Table CureVac COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table CureVac COVID-19 RNA Vaccine Product and Service
-
Table Moderna (Foundation Year, Company Profile and etc.)
-
Table Moderna COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Moderna COVID-19 RNA Vaccine Product and Service
-
Table Zhuhai Livanda Biotechnology Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Zhuhai Livanda Biotechnology Co, Ltd COVID-19 RNA Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhuhai Livanda Biotechnology Co, Ltd COVID-19 RNA Vaccine Product and Service
-
